Variability in the management of childhood constipation

Related Experiment Videos

Dean R Focht1, Raymond C Baker, James E Heubi

  • 1Division of Pediatric Gastroenterology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Clinical Pediatrics
|May 19, 2006
PubMed

Insights

Most pediatricians treat childhood constipation with polyethylene glycol, but few are aware of clinical guidelines. Parental pressure influences referrals to specialists, highlighting a gap in guideline adoption for pediatric constipation management.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Practice Guidelines
  • Primary Care Management

Background:

  • Childhood constipation is a common pediatric issue.
  • Clinical practice guidelines were developed by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) to standardize management.
  • Primary care providers' adherence to these guidelines is not well understood.

Purpose of the Study:

  • To evaluate current constipation management strategies used by pediatricians in the United States.
  • To assess pediatrician awareness of NASPGHAN constipation guidelines.
  • To identify reasons for referring pediatric patients with constipation to a pediatric gastroenterologist.

Main Methods:

  • A cross-sectional survey was distributed to pediatricians nationwide.
  • The survey assessed treatment preferences, guideline awareness, and referral patterns.
  • Data analysis focused on common practices and awareness levels.

Main Results:

  • 75% of surveyed pediatricians utilize polyethylene glycol without electrolytes for constipation.
  • Only 8% of pediatricians reported awareness of the NASPGHAN constipation guidelines.
  • Parental pressure was identified as one of several factors influencing specialist referrals.

Conclusions:

  • Pediatrician practices for childhood constipation show a high utilization of polyethylene glycol.
  • There is low awareness of NASPGHAN clinical practice guidelines among pediatricians, indicating a need for improved dissemination and education.
  • Referral decisions are multifactorial, with parental influence playing a role alongside clinical judgment.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD: